Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Trial Profile

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Phase of Trial: Phase II

Latest Information Update: 23 Mar 2015

At a glance

  • Drugs Lenalidomide (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Feb 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 20 Nov 2012 Planned end date changed from 1 Dec 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 23 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top